Copyright Reports & Markets. All rights reserved.

Global Molecular Testing for Respiratory Pathogens Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Molecular Testing for Respiratory Pathogens Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Single Pathogen Test
    • 1.3.3 Multiple Pathogen Test
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Molecular Testing for Respiratory Pathogens Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Diagnostic Laboratories
  • 1.5 Global Molecular Testing for Respiratory Pathogens Market Size & Forecast
    • 1.5.1 Global Molecular Testing for Respiratory Pathogens Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Molecular Testing for Respiratory Pathogens Sales Quantity (2021-2032)
    • 1.5.3 Global Molecular Testing for Respiratory Pathogens Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 BioFire Diagnostics
    • 2.1.1 BioFire Diagnostics Details
    • 2.1.2 BioFire Diagnostics Major Business
    • 2.1.3 BioFire Diagnostics Molecular Testing for Respiratory Pathogens Product and Services
    • 2.1.4 BioFire Diagnostics Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BioFire Diagnostics Recent Developments/Updates
  • 2.2 DiaSorin
    • 2.2.1 DiaSorin Details
    • 2.2.2 DiaSorin Major Business
    • 2.2.3 DiaSorin Molecular Testing for Respiratory Pathogens Product and Services
    • 2.2.4 DiaSorin Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 DiaSorin Recent Developments/Updates
  • 2.3 Seegene
    • 2.3.1 Seegene Details
    • 2.3.2 Seegene Major Business
    • 2.3.3 Seegene Molecular Testing for Respiratory Pathogens Product and Services
    • 2.3.4 Seegene Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Seegene Recent Developments/Updates
  • 2.4 Qiagen
    • 2.4.1 Qiagen Details
    • 2.4.2 Qiagen Major Business
    • 2.4.3 Qiagen Molecular Testing for Respiratory Pathogens Product and Services
    • 2.4.4 Qiagen Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Qiagen Recent Developments/Updates
  • 2.5 Hoffmann-La Roche
    • 2.5.1 Hoffmann-La Roche Details
    • 2.5.2 Hoffmann-La Roche Major Business
    • 2.5.3 Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Product and Services
    • 2.5.4 Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hoffmann-La Roche Recent Developments/Updates
  • 2.6 Cepheid (Danaher)
    • 2.6.1 Cepheid (Danaher) Details
    • 2.6.2 Cepheid (Danaher) Major Business
    • 2.6.3 Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Product and Services
    • 2.6.4 Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Cepheid (Danaher) Recent Developments/Updates
  • 2.7 Abbott Laboratories
    • 2.7.1 Abbott Laboratories Details
    • 2.7.2 Abbott Laboratories Major Business
    • 2.7.3 Abbott Laboratories Molecular Testing for Respiratory Pathogens Product and Services
    • 2.7.4 Abbott Laboratories Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Abbott Laboratories Recent Developments/Updates
  • 2.8 QuidelOrtho
    • 2.8.1 QuidelOrtho Details
    • 2.8.2 QuidelOrtho Major Business
    • 2.8.3 QuidelOrtho Molecular Testing for Respiratory Pathogens Product and Services
    • 2.8.4 QuidelOrtho Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 QuidelOrtho Recent Developments/Updates
  • 2.9 Illumina
    • 2.9.1 Illumina Details
    • 2.9.2 Illumina Major Business
    • 2.9.3 Illumina Molecular Testing for Respiratory Pathogens Product and Services
    • 2.9.4 Illumina Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Illumina Recent Developments/Updates
  • 2.10 ZeptoMetrix
    • 2.10.1 ZeptoMetrix Details
    • 2.10.2 ZeptoMetrix Major Business
    • 2.10.3 ZeptoMetrix Molecular Testing for Respiratory Pathogens Product and Services
    • 2.10.4 ZeptoMetrix Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 ZeptoMetrix Recent Developments/Updates
  • 2.11 Sansure
    • 2.11.1 Sansure Details
    • 2.11.2 Sansure Major Business
    • 2.11.3 Sansure Molecular Testing for Respiratory Pathogens Product and Services
    • 2.11.4 Sansure Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sansure Recent Developments/Updates
  • 2.12 BGI Genomics
    • 2.12.1 BGI Genomics Details
    • 2.12.2 BGI Genomics Major Business
    • 2.12.3 BGI Genomics Molecular Testing for Respiratory Pathogens Product and Services
    • 2.12.4 BGI Genomics Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 BGI Genomics Recent Developments/Updates
  • 2.13 bioMérieux
    • 2.13.1 bioMérieux Details
    • 2.13.2 bioMérieux Major Business
    • 2.13.3 bioMérieux Molecular Testing for Respiratory Pathogens Product and Services
    • 2.13.4 bioMérieux Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 bioMérieux Recent Developments/Updates
  • 2.14 AusDiagnostics
    • 2.14.1 AusDiagnostics Details
    • 2.14.2 AusDiagnostics Major Business
    • 2.14.3 AusDiagnostics Molecular Testing for Respiratory Pathogens Product and Services
    • 2.14.4 AusDiagnostics Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 AusDiagnostics Recent Developments/Updates
  • 2.15 Anatolia Geneworks
    • 2.15.1 Anatolia Geneworks Details
    • 2.15.2 Anatolia Geneworks Major Business
    • 2.15.3 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Product and Services
    • 2.15.4 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Anatolia Geneworks Recent Developments/Updates
  • 2.16 DaAn Gene
    • 2.16.1 DaAn Gene Details
    • 2.16.2 DaAn Gene Major Business
    • 2.16.3 DaAn Gene Molecular Testing for Respiratory Pathogens Product and Services
    • 2.16.4 DaAn Gene Molecular Testing for Respiratory Pathogens Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 DaAn Gene Recent Developments/Updates

3 Competitive Environment: Molecular Testing for Respiratory Pathogens by Manufacturer

  • 3.1 Global Molecular Testing for Respiratory Pathogens Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Molecular Testing for Respiratory Pathogens Revenue by Manufacturer (2021-2026)
  • 3.3 Global Molecular Testing for Respiratory Pathogens Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Molecular Testing for Respiratory Pathogens by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Molecular Testing for Respiratory Pathogens Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Molecular Testing for Respiratory Pathogens Manufacturer Market Share in 2025
  • 3.5 Molecular Testing for Respiratory Pathogens Market: Overall Company Footprint Analysis
    • 3.5.1 Molecular Testing for Respiratory Pathogens Market: Region Footprint
    • 3.5.2 Molecular Testing for Respiratory Pathogens Market: Company Product Type Footprint
    • 3.5.3 Molecular Testing for Respiratory Pathogens Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Molecular Testing for Respiratory Pathogens Market Size by Region
    • 4.1.1 Global Molecular Testing for Respiratory Pathogens Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Molecular Testing for Respiratory Pathogens Consumption Value by Region (2021-2032)
    • 4.1.3 Global Molecular Testing for Respiratory Pathogens Average Price by Region (2021-2032)
  • 4.2 North America Molecular Testing for Respiratory Pathogens Consumption Value (2021-2032)
  • 4.3 Europe Molecular Testing for Respiratory Pathogens Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Molecular Testing for Respiratory Pathogens Consumption Value (2021-2032)
  • 4.5 South America Molecular Testing for Respiratory Pathogens Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Molecular Testing for Respiratory Pathogens Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Molecular Testing for Respiratory Pathogens Sales Quantity by Type (2021-2032)
  • 5.2 Global Molecular Testing for Respiratory Pathogens Consumption Value by Type (2021-2032)
  • 5.3 Global Molecular Testing for Respiratory Pathogens Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Molecular Testing for Respiratory Pathogens Sales Quantity by Application (2021-2032)
  • 6.2 Global Molecular Testing for Respiratory Pathogens Consumption Value by Application (2021-2032)
  • 6.3 Global Molecular Testing for Respiratory Pathogens Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Molecular Testing for Respiratory Pathogens Sales Quantity by Type (2021-2032)
  • 7.2 North America Molecular Testing for Respiratory Pathogens Sales Quantity by Application (2021-2032)
  • 7.3 North America Molecular Testing for Respiratory Pathogens Market Size by Country
    • 7.3.1 North America Molecular Testing for Respiratory Pathogens Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Molecular Testing for Respiratory Pathogens Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Molecular Testing for Respiratory Pathogens Sales Quantity by Type (2021-2032)
  • 8.2 Europe Molecular Testing for Respiratory Pathogens Sales Quantity by Application (2021-2032)
  • 8.3 Europe Molecular Testing for Respiratory Pathogens Market Size by Country
    • 8.3.1 Europe Molecular Testing for Respiratory Pathogens Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Molecular Testing for Respiratory Pathogens Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Molecular Testing for Respiratory Pathogens Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Molecular Testing for Respiratory Pathogens Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Molecular Testing for Respiratory Pathogens Market Size by Region
    • 9.3.1 Asia-Pacific Molecular Testing for Respiratory Pathogens Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Molecular Testing for Respiratory Pathogens Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Molecular Testing for Respiratory Pathogens Sales Quantity by Type (2021-2032)
  • 10.2 South America Molecular Testing for Respiratory Pathogens Sales Quantity by Application (2021-2032)
  • 10.3 South America Molecular Testing for Respiratory Pathogens Market Size by Country
    • 10.3.1 South America Molecular Testing for Respiratory Pathogens Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Molecular Testing for Respiratory Pathogens Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Molecular Testing for Respiratory Pathogens Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Molecular Testing for Respiratory Pathogens Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Molecular Testing for Respiratory Pathogens Market Size by Country
    • 11.3.1 Middle East & Africa Molecular Testing for Respiratory Pathogens Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Molecular Testing for Respiratory Pathogens Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Molecular Testing for Respiratory Pathogens Market Drivers
  • 12.2 Molecular Testing for Respiratory Pathogens Market Restraints
  • 12.3 Molecular Testing for Respiratory Pathogens Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Molecular Testing for Respiratory Pathogens and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Molecular Testing for Respiratory Pathogens
  • 13.3 Molecular Testing for Respiratory Pathogens Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Molecular Testing for Respiratory Pathogens Typical Distributors
  • 14.3 Molecular Testing for Respiratory Pathogens Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Molecular Testing for Respiratory Pathogens market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Molecular testing for respiratory pathogens involves the use of molecular biology techniques to detect and identify viruses and bacteria causing respiratory infections. Utilizing nucleic acid amplification methods such as polymerase chain reaction (PCR), these tests target specific genetic material unique to pathogens, allowing for sensitive and rapid identification. Molecular assays enable simultaneous detection of multiple respiratory pathogens in a single test, providing comprehensive results for viruses like influenza, respiratory syncytial virus (RSV), and various strains of coronaviruses. These tests play a crucial role in diagnosing respiratory infections accurately, aiding in patient management, infection control, and public health surveillance.
    The market for molecular diagnostics in infectious diseases is characterized by rapid technological advancements and a growing emphasis on accurate and timely disease detection. Molecular diagnostics involve the identification of pathogens at the molecular level, enabling quicker and more precise diagnosis of infectious diseases. Factors such as the increasing incidence of infectious diseases, demand for point-of-care testing, and advancements in genomics contribute to the market"s expansion. Key players in the industry focus on developing innovative diagnostic platforms and expanding their product portfolios to meet the rising demand for molecular diagnostic solutions. The market is anticipated to experience continuous growth as molecular diagnostics become integral in managing infectious diseases globally, offering benefits such as early detection, personalized treatment strategies, and monitoring of treatment effectiveness.
    This report is a detailed and comprehensive analysis for global Molecular Testing for Respiratory Pathogens market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Molecular Testing for Respiratory Pathogens market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Molecular Testing for Respiratory Pathogens market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Molecular Testing for Respiratory Pathogens market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Molecular Testing for Respiratory Pathogens market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Molecular Testing for Respiratory Pathogens
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Molecular Testing for Respiratory Pathogens market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioFire Diagnostics, DiaSorin, Seegene, Qiagen, Hoffmann-La Roche, Cepheid (Danaher), Abbott Laboratories, QuidelOrtho, Illumina, ZeptoMetrix, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Molecular Testing for Respiratory Pathogens market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Single Pathogen Test
    Multiple Pathogen Test
    Market segment by Application
    Hospital
    Diagnostic Laboratories
    Major players covered
    BioFire Diagnostics
    DiaSorin
    Seegene
    Qiagen
    Hoffmann-La Roche
    Cepheid (Danaher)
    Abbott Laboratories
    QuidelOrtho
    Illumina
    ZeptoMetrix
    Sansure
    BGI Genomics
    bioMérieux
    AusDiagnostics
    Anatolia Geneworks
    DaAn Gene
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Molecular Testing for Respiratory Pathogens product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Molecular Testing for Respiratory Pathogens, with price, sales quantity, revenue, and global market share of Molecular Testing for Respiratory Pathogens from 2021 to 2026.
    Chapter 3, the Molecular Testing for Respiratory Pathogens competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Molecular Testing for Respiratory Pathogens breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Molecular Testing for Respiratory Pathogens market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Molecular Testing for Respiratory Pathogens.
    Chapter 14 and 15, to describe Molecular Testing for Respiratory Pathogens sales channel, distributors, customers, research findings and conclusion.

    Buy now